BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35750880)

  • 1. Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression.
    Comba A; Faisal SM; Dunn PJ; Argento AE; Hollon TC; Al-Holou WN; Varela ML; Zamler DB; Quass GL; Apostolides PF; Abel C; Brown CE; Kish PE; Kahana A; Kleer CG; Motsch S; Castro MG; Lowenstein PR
    Nat Commun; 2022 Jun; 13(1):3606. PubMed ID: 35750880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal Insights into Glioma Oncostream Dynamics: Unraveling Formation, Stability, and Disassembly Pathways.
    Faisal SM; Clewner JE; Stack B; Varela ML; Comba A; Abbud G; Motsch S; Castro MG; Lowenstein PR
    Adv Sci (Weinh); 2024 May; 11(18):e2309796. PubMed ID: 38384234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion.
    Comba A; Dunn PJ; Kish PE; Kadiyala P; Kahana A; Castro MG; Lowenstein PR
    J Vis Exp; 2020 Apr; (158):. PubMed ID: 32338655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
    Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
    Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The landscape of the mesenchymal signature in brain tumours.
    Behnan J; Finocchiaro G; Hanna G
    Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma.
    Rajendran S; Hu Y; Canella A; Peterson C; Gross A; Cam M; Nazzaro M; Haffey A; Serin-Harmanci A; Distefano R; Nigita G; Wang W; Kreatsoulas D; Li Z; Sepeda JA; Sas A; Hester ME; Miller KE; Elemento O; Roberts RD; Holland EC; Rao G; Mardis ER; Rajappa P
    Cell Rep; 2023 Mar; 42(3):112197. PubMed ID: 36871221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling.
    Natesh K; Bhosale D; Desai A; Chandrika G; Pujari R; Jagtap J; Chugh A; Ranade D; Shastry P
    Neoplasia; 2015 Feb; 17(2):225-37. PubMed ID: 25748242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.
    Moncayo G; Grzmil M; Smirnova T; Zmarz P; Huber RM; Hynx D; Kohler H; Wang Y; Hotz HR; Hynes NE; Keller G; Frank S; Merlo A; Hemmings BA
    Neuro Oncol; 2018 Apr; 20(5):621-631. PubMed ID: 29401256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.
    Latha K; Yan J; Yang Y; Gressot LV; Kong LY; Manyam G; Ezhilarasan R; Wang Q; Sulman EP; Eric Davis R; Huang S; Fuller GN; Rao A; Heimberger AB; Li S; Rao G
    J Natl Cancer Inst; 2019 Mar; 111(3):292-300. PubMed ID: 29947810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
    Li YF; Tsai WC; Chou CH; Huang LC; Huang SM; Hueng DY; Tsai CK
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance.
    Diaz RJ; Dios RR; Hattab EM; Burrell K; Rakopoulos P; Sabha N; Hawkins C; Zadeh G; Rutka JT; Cohen-Gadol AA
    J Neurosurg; 2015 Jun; 122(6):1360-9. PubMed ID: 25839919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tweety-Homolog 1 Drives Brain Colonization of Gliomas.
    Jung E; Osswald M; Blaes J; Wiestler B; Sahm F; Schmenger T; Solecki G; Deumelandt K; Kurz FT; Xie R; Weil S; Heil O; Thomé C; Gömmel M; Syed M; Häring P; Huber PE; Heiland S; Platten M; von Deimling A; Wick W; Winkler F
    J Neurosci; 2017 Jul; 37(29):6837-6850. PubMed ID: 28607172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of COL1A1 associated with immune infiltration in brain lower grade glioma.
    Ren J; Da J; Hu N
    PLoS One; 2022; 17(7):e0269533. PubMed ID: 35789341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
    Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
    J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas.
    Yi L; Fan X; Li J; Yuan F; Zhao J; Nistér M; Yang X
    Aging (Albany NY); 2021 Jan; 13(3):3645-3660. PubMed ID: 33493139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.
    Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D
    Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma: molecular signature and crossroads with tumor microenvironment.
    Barthel L; Hadamitzky M; Dammann P; Schedlowski M; Sure U; Thakur BK; Hetze S
    Cancer Metastasis Rev; 2022 Mar; 41(1):53-75. PubMed ID: 34687436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
    Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
    Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.